Literature DB >> 26755862

Four-dimensional flow magnetic resonance imaging in cirrhosis.

Zoran Stankovic1.   

Abstract

Since its introduction in the 1970's, magnetic resonance imaging (MRI) has become a standard imaging modality. With its broad and standardized application, it is firmly established in the clinical routine and an essential element in cardiovascular and abdominal imaging. In addition to sonography and computer tomography, MRI is a valuable tool for diagnosing cardiovascular and abdominal diseases, for determining disease severity, and for assessing therapeutic success. MRI techniques have improved over the last few decades, revealing not just morphologic information, but functional information about perfusion, diffusion and hemodynamics as well. Four-dimensional (4D) flow MRI, a time-resolved phase contrast-MRI with three-dimensional (3D) anatomic coverage and velocity encoding along all three flow directions has been used to comprehensively assess complex cardiovascular hemodynamics in multiple regions of the body. The technique enables visualization of 3D blood flow patterns and retrospective quantification of blood flow parameters in a region of interest. Over the last few years, 4D flow MRI has been increasingly performed in the abdominal region. By applying different acceleration techniques, taking 4D flow MRI measurements has dropped to a reasonable scanning time of 8 to 12 min. These new developments have encouraged a growing number of patient studies in the literature validating the technique's potential for enhanced evaluation of blood flow parameters within the liver's complex vascular system. The purpose of this review article is to broaden our understanding of 4D flow MRI for the assessment of liver hemodynamics by providing insights into acquisition, data analysis, visualization and quantification. Furthermore, in this article we highlight its development, focussing on the clinical application of the technique.

Entities:  

Keywords:  Blood flow; Four-dimensional flow magnetic resonance imaging; Hemodynamics; Imaging technique; Liver cirrhosis; Phase contrast-magnetic resonance imaging; Quantification; Splanchnic system; TIPS; Visualization

Mesh:

Year:  2016        PMID: 26755862      PMCID: PMC4698511          DOI: 10.3748/wjg.v22.i1.89

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  169 in total

1.  k-t BLAST and k-t SENSE: dynamic MRI with high frame rate exploiting spatiotemporal correlations.

Authors:  Jeffrey Tsao; Peter Boesiger; Klaas P Pruessmann
Journal:  Magn Reson Med       Date:  2003-11       Impact factor: 4.668

2.  Flow patterns in the aortic root and the aorta studied with time-resolved, 3-dimensional, phase-contrast magnetic resonance imaging: implications for aortic valve-sparing surgery.

Authors:  John-Peder Escobar Kvitting; Tino Ebbers; Lars Wigström; Jan Engvall; Christian L Olin; Ann F Bolger
Journal:  J Thorac Cardiovasc Surg       Date:  2004-06       Impact factor: 5.209

3.  Usefulness of 4D MRI flow imaging to control TIPS function.

Authors:  Zoran Stankovic; Philipp Blanke; Michael Markl
Journal:  Am J Gastroenterol       Date:  2012-02       Impact factor: 10.864

4.  4D phase-contrast flow cardiovascular magnetic resonance: comprehensive quantification and visualization of flow dynamics in atrial septal defect and partial anomalous pulmonary venous return.

Authors:  Israel Valverde; John Simpson; Tobias Schaeffter; Philipp Beerbaum
Journal:  Pediatr Cardiol       Date:  2010-09-17       Impact factor: 1.655

5.  Magnetic resonance elastography for the noninvasive staging of liver fibrosis.

Authors:  Laurent Huwart; Christine Sempoux; Eric Vicaut; Najat Salameh; Laurence Annet; Etienne Danse; Frank Peeters; Leon C ter Beek; Jacques Rahier; Ralph Sinkus; Yves Horsmans; Bernard E Van Beers
Journal:  Gastroenterology       Date:  2008-04-04       Impact factor: 22.682

6.  Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging.

Authors:  Diego A Aguirre; Cynthia A Behling; Elliot Alpert; Tarek I Hassanein; Claude B Sirlin
Journal:  Radiology       Date:  2006-05       Impact factor: 11.105

7.  In vivo validation of 4D flow MRI for assessing the hemodynamics of portal hypertension.

Authors:  Alejandro Roldán-Alzate; Alex Frydrychowicz; Eric Niespodzany; Ben R Landgraf; Kevin M Johnson; Oliver Wieben; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2012-11-12       Impact factor: 4.813

8.  Evaluation of regional hepatic perfusion (RHP) by contrast-enhanced ultrasound in patients with cirrhosis.

Authors:  Annalisa Berzigotti; Carlos Nicolau; Pablo Bellot; Juan G Abraldes; Rosa Gilabert; Juan Carlos García-Pagan; Jaime Bosch
Journal:  J Hepatol       Date:  2010-12-15       Impact factor: 25.083

9.  Noninvasive diagnosis of hepatic fibrosis or cirrhosis.

Authors:  F Oberti; E Valsesia; C Pilette; M C Rousselet; P Bedossa; C Aubé; Y Gallois; H Rifflet; M Y Maïga; D Penneau-Fontbonne; P Calès
Journal:  Gastroenterology       Date:  1997-11       Impact factor: 22.682

10.  Duplex Doppler measurements of portal venous flow in normal subjects. Inter- and intra-observer variability.

Authors:  P J de Vries; J van Hattum; J B Hoekstra; P de Hooge
Journal:  J Hepatol       Date:  1991-11       Impact factor: 25.083

View more
  5 in total

Review 1.  Noninvasive imaging assessment of portal hypertension.

Authors:  Paul Kennedy; Octavia Bane; Stefanie J Hectors; Aaron Fischman; Thomas Schiano; Sara Lewis; Bachir Taouli
Journal:  Abdom Radiol (NY)       Date:  2020-09-14

2.  Blood Flow Lateralization and Collateral Compensatory Mechanisms in Patients With Carotid Artery Stenosis.

Authors:  Laleh Zarrinkoob; Anders Wåhlin; Khalid Ambarki; Richard Birgander; Anders Eklund; Jan Malm
Journal:  Stroke       Date:  2019-05       Impact factor: 7.914

3.  Kat-ARC accelerated 4D flow CMR: clinical validation for transvalvular flow and peak velocity assessment.

Authors:  Hosamadin Assadi; Bhalraam Uthayachandran; Rui Li; James Wardley; Tha H Nyi; Ciaran Grafton-Clarke; Andrew J Swift; Ana Beatriz Solana; Jean-Paul Aben; Kurian Thampi; David Hewson; Chris Sawh; Richard Greenwood; Marina Hughes; Bahman Kasmai; Liang Zhong; Marcus Flather; Vassilios S Vassiliou; Pankaj Garg
Journal:  Eur Radiol Exp       Date:  2022-09-22

4.  Beneficial long term effect of a phosphodiesterase-5-inhibitor in cirrhotic portal hypertension: A case report with 8 years follow-up.

Authors:  Peter Deibert; Adhara Lazaro; Zoran Stankovic; Denise Schaffner; Martin Rössle; Wolfgang Kreisel
Journal:  World J Gastroenterol       Date:  2018-01-21       Impact factor: 5.742

5.  Establishment and assessment of the hepatic venous pressure gradient using biofluid mechanics (HVPGBFM): protocol for a prospective, randomised, non-controlled, multicentre study.

Authors:  Jia-Yun Lin; Chi-Hao Zhang; Lei Zheng; Hui-Song Chen; Hong-Jie Li; Yi-Ming Zhu; Xiao Fan; Feng Li; Yan Xia; Ming-Zhe Huang; Sun-Hu Yang; Xiao-Liang Qi; Hai-Zhong Huo; Xiao-Lou Lou; Meng Luo
Journal:  BMJ Open       Date:  2019-12-03       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.